Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics
Open Access
- 24 February 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 124 (9) , 2106-2115
Abstract
To develop a prognostic biomarker for esophageal squamous cell carcinoma (ESCC), we examined the proteomic profile of ESCC using two‐dimensional difference gel electrophoresis (2D‐DIGE), and identified proteins associated with prognosis by mass spectrometry. The prognostic performance of the identified proteins was examined by immunohistochemistry in additional cases. We identified 22 protein spots whose intensity was statistically different between ESCC cases with good (N = 9; survived more than 5 years without evidence of recurrence) and poor (N = 24; died within 2 years postsurgery) prognosis, within the patient group that had two or more lymph node metastases. Mass spectrometric protein identification resulted in 18 distinct gene products from the 22 protein spots. Transglutaminase 3 (TGM3) was inversely correlated with shorter patient survival. The prognostic performance of TGM3 was further examined by immunohistochemistry in 76 ESCC cases. The 5‐year disease‐specific survival rate was 64.5% and 32.1% for patients with TGM3‐positive and TGM3‐negative tumors, respectively (p = 0.0033). Univariate and multivariate analyses revealed that TGM3 expression was an independent prognostic factor among the clinicopathologic variables examined. It is noteworthy that the prognostic value of TGM3 was shown to be higher than those of the lymph node metastasis, intramural metastasis and vascular invasion status. These results establish TGM3 as a novel prognostic biomarker for ESCC for the first time. Examination of TGM3 expression may provide novel therapeutic strategies to prevent recurrence of ESCC.Keywords
This publication has 45 references indexed in Scilit:
- Tumor‐specific genetic expression profile of metastatic oral squamous cell carcinomaHead & Neck, 2007
- Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1αBiochemical Journal, 2007
- Cellular and Network Mechanisms of Spike‐Wave SeizuresEpilepsia, 2005
- The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cellsBiochemical Journal, 2005
- Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent diseaseCancer, 2003
- A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan clinical oncology group studyThe Journal of Thoracic and Cardiovascular Surgery, 1997
- The Proximal Promoter of the Human Transglutaminase 3 GeneJournal of Biological Chemistry, 1996
- High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosisCancer, 1994
- P53 protein expression and prognosis in squamous cell carcinoma of the esophagusCancer, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958